Anticorps Recombinant de lapin anti-Phospho-Histone H3 (Thr3)
Phospho-Histone H3 (Thr3) Recombinant Antibody for WB, IF/ICC, FC (Intra), Indirect ELISA, ChIP-qPCR
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IF/ICC, FC (Intra), Indirect ELISA, ChIP-qPCR
Conjugaison
Non conjugué
CloneNo.
241897G3
N° de cat : 84739-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
84739-1-PBS cible Phospho-Histone H3 (Thr3) dans les applications de WB, IF/ICC, FC (Intra), Indirect ELISA, ChIP-qPCR et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | Peptide |
| Nom complet | histone cluster 1, H3a |
| Poids moléculaire observé | 15 kDa |
| Numéro d’acquisition GenBank | BC066245 |
| Symbole du gène | HIST1H3A |
| Identification du gène (NCBI) | 8350 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Protein A purfication |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
Phospho-histone-H3 (PHH3) is a core histone protein, which in its phosphorylated state forms the principal constituents of eukaryotic chromatin, with histone H3 being phosphorylated at serine (Ser) 10 or Ser28 as well as its phosphorylation of Ser10 being strongly correlated with the late G2 to M-phase transition in mammalian mitotic cells. On the basis of previous research, a few cell line- and animal model-based researches have displayed an increase in phosphorylation of histone H3 at Ser10 (H3S10ph), the only histone marker that is involved in carcinogenesis and cellular transformation. Histone H3 phosphorylation on serine-10 is specific to mitosis and phosphorylated histone H3 (PHH3) proliferation markers (as counts defined per area or as indices defined per cell numbers) are increasingly being used to evaluate proliferation in various tumors.







